Indirect immunofluorescence is still relevant in the detection of glutamic acid decarboxylase (GAD) 65 antibody in neurological disease: reply
Pathology · 2023
DOI: 10.1016/j.pathol.2023.09.002 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pathology, 2023. Verfasst von Amelia Cecchin und 1 weiteren Autor:innen. Beteiligte Einrichtung: SA Pathology, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Glutamate Decarboxylase, Nervous System Diseases. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- SA Pathology, Adelaide, SA, Australia.
- SA Pathology, Adelaide, SA, Australia; Royal Adelaide Hospital, Adelaide, SA, Australia; University of Adelaide, Adelaide, SA, Australia. Electronic address: Pravin.Hissaria@sa.gov.au.
Zitieren
APA
Cecchin, A., & Hissaria, P. (2023). Indirect immunofluorescence is still relevant in the detection of glutamic acid decarboxylase (GAD) 65 antibody in neurological disease: reply. Pathology. https://doi.org/10.1016/j.pathol.2023.09.002
Vancouver
Cecchin A, Hissaria P. Indirect immunofluorescence is still relevant in the detection of glutamic acid decarboxylase (GAD) 65 antibody in neurological disease: reply. Pathology. 2023. doi:10.1016/j.pathol.2023.09.002
BibTeX
@article{Cecchin2023,
author = {Cecchin, Amelia and Hissaria, Pravin},
title = {Indirect immunofluorescence is still relevant in the detection of glutamic acid decarboxylase (GAD) 65 antibody in neurological disease: reply},
journal = {Pathology},
year = {2023},
doi = {10.1016/j.pathol.2023.09.002}
}
EUVIMED